Historical record - last NADAC effective date: 10/19/2016
Product Information
FENTANYL CITRATE OTFC 800 MCG is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $12.7517 per EA under NDC 00093786865. Its NADAC has been published 98 times since Jan 6, 2016.
FDA first approved this application on Nov 4, 1998.
The High Outlier badge above means this manufacturer's average price in the Fentanyl Citrate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
800 ug/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093786865
Classification
Generic
Dosage Form
LOZENGE
Route
ORAL; TRANSMUCOSAL
Effective Date
10/19/2016
Active Ingredients
FENTANYL CITRATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA020747FDA Approved
11/4/1998
On Market Since
12/8/2015
Pharmacological Classes
Price Statistics
The NADAC for FENTANYL CITRATE OTFC 800 MCG has been published 98 times since Jan 6, 2016, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $12.7517 per EA |
|---|---|
| All-time high | $13.8343 (Sep 14, 2016) |
| All-time low | $11.5491 (Sep 21, 2016) |
| Median price | $12.7517 |
| Average price | $12.8651 |
| Largest weekly change | -16.5% (Sep 21, 2016) |
| Weeks tracked | 98 |
| Tracking since | Jan 6, 2016 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+1.5%
Last surveyed Nov 15, 2017 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Fentanyl Citrate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of FENTANYL CITRATE OTFC 800 MCG?
The current National Average Drug Acquisition Cost (NADAC) for FENTANYL CITRATE OTFC 800 MCG, manufactured by Teva Pharmaceuticals USA Inc., is $12.7517 per EA (NDC 00093786865), effective Nov 15, 2017.
How has the price of FENTANYL CITRATE OTFC 800 MCG changed over time?
Over the history we have for it, the NADAC for FENTANYL CITRATE OTFC 800 MCG has held within roughly two percent of its current level. It has been tracked across 98 weekly CMS publications since Jan 6, 2016.
What are the highest and lowest recorded NADAC prices for FENTANYL CITRATE OTFC 800 MCG?
Since Jan 6, 2016, the NADAC for FENTANYL CITRATE OTFC 800 MCG has ranged from a low of $11.5491 (Sep 21, 2016) to a high of $13.8343 (Sep 14, 2016), with a median of $12.7517 per EA.
Are there cheaper alternatives to FENTANYL CITRATE OTFC 800 MCG?
No other NADAC-published product currently shares the active ingredient and strength of FENTANYL CITRATE OTFC 800 MCG in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures FENTANYL CITRATE OTFC 800 MCG?
FENTANYL CITRATE OTFC 800 MCG (NDC 00093786865) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.